Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design.
Basic Information
ID: ALA4033798
Journal: J Med Chem
Title: Discovery of Novel KRAS-PDEδ Inhibitors by Fragment-Based Drug Design.
Authors: Chen L, Zhuang C, Lu J, Jiang Y, Sheng C.
Abstract: Targeting KRAS-PDEδ protein-protein interactions with small molecules represents a promising opportunity for developing novel antitumor agents. However, current KRAS-PDEδ inhibitors are limited by poor cellular antitumor potency and the druggability of the target remains to be validated by new inhibitors. To tackle these challenges, herein, novel, highly potent KRAS-PDEδ inhibitors were identified by fragment-based drug design, providing promising lead compounds or chemical probes for investigating the biological functions and druggability of KRAS-PDEδ interaction.
CiteXplore: 29510040
DOI: 10.1021/acs.jmedchem.8b00057
Patent ID: ┄